Zhou Shi-Hai, Xiong Ya-Qun, Chen Ya
Department of Pharmacy, Guihang Guiyang Hospital, Guiyang 550001, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Apr 15;24(4):447-453. doi: 10.7499/j.issn.1008-8830.2201081.
Tofacitinib is a Janus kinase inhibitor and can block the Janus kinase-signal transducer and activator of transcription signal transduction pathway and reduce the production and release of a variety of cytokines. It has great potential in the treatment of various rheumatic diseases with a rapid onset of action and can reduce corticosteroid dependence and related adverse events. The therapeutic effect of tofacitinib in adult patients has been confirmed, and it has been increasingly used in pediatric patients in recent years. This article reviews the clinical application of tofacitinib in the treatment of pediatric autoimmune diseases.
托法替布是一种Janus激酶抑制剂，可阻断Janus激酶-信号转导子和转录激活子信号转导通路，减少多种细胞因子的产生和释放。它在治疗各种风湿性疾病方面具有巨大潜力，起效迅速，可减少对皮质类固醇的依赖及相关不良事件。托法替布在成年患者中的治疗效果已得到证实，近年来在儿科患者中的应用也越来越多。本文综述了托法替布在儿科自身免疫性疾病治疗中的临床应用。
